GPC3 and hepatocellular carcinoma: The clinical application value of each model was assessed using DCA (Figure 7A) and showed that the nomogram yielded a higher net clinical benefit than the radiomic and clinicoradiologic models, indicating the clinical utility for GPC3-positive patients with HCC.